MYC and MYCN amplification can be reliably assessed by aCGH in medulloblastoma-Reference-Cited by-同舟云学术

MYC and MYCN amplification can be reliably assessed by aCGH in medulloblastoma

Published:2013-04 Issue:4 Volume:206 Page:124-129
ISSN:2210-7762
Container-title:Cancer Genetics
language:en
Short-container-title:Cancer Genetics

Author:

Bourdeaut Franck,Grison Camille,Maurage Claude-Alain,Laquerriere Annie,Vasiljevic Alexandre,Delisle Marie-Bernadette,Michalak Sophie,Figarella-Branger Dominique,Doz François,Richer Wilfrid,Pierron Gaelle,Miquel Catherine,Delattre Olivier,Couturier Jérôme

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Molecular Biology

Reference18 articles.

1. Medulloblastomas: update on a heterogeneous disease;Bourdeaut;Curr Opin Oncol,2011

2. Molecular subgroups of medulloblastoma: the current consensus;Taylor;Acta Neuropathol,2012

3. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci;Pfister;J Clin Oncol,2009

4. Two types of chromosome 1p losses with opposite significance in gliomas;Idbaih;Ann Neurol,2005

5. ESR1 gene amplification in breast cancer: a common phenomenon?;Vincent-Salomon;Nat Genet,2008

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medulloblastoma oncogene aberrations are not involved in tumor initiation, but essential for disease progression and therapy resistance;2024-02-12

2. Case report of a pediatric medulloblastoma with concurrent MYC and MYCN subclonal amplification in distinct populations of neoplastic cells;Virchows Archiv;2023-05-22

3. Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnostics;Neuropathology and Applied Neurobiology;2021-05-02

4. Pathology, diagnostics, and classification of medulloblastoma;Brain Pathology;2020-05

5. Genomic Profiles of Neuroblastoma Associated With Opsoclonus Myoclonus Syndrome;Journal of Pediatric Hematology/Oncology;2018-03